Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi Sells 35,000 Shares

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the transaction, the director now directly owns 35,609 shares in the company, valued at $2,349,837.91. The trade was a 49.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total value of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 0.2 %

Shares of NYSE RYAN traded down $0.12 during trading on Wednesday, reaching $66.20. The company had a trading volume of 704,356 shares, compared to its average volume of 1,169,740. Ryan Specialty Holdings, Inc. has a 12 month low of $42.21 and a 12 month high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market cap of $17.33 billion, a P/E ratio of 85.97, a PEG ratio of 1.52 and a beta of 0.72. The company’s fifty day moving average price is $68.19 and its 200-day moving average price is $65.80.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. During the same period in the prior year, the business posted $0.32 earnings per share. The firm’s revenue was up 20.5% on a year-over-year basis. As a group, research analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Wall Street Analysts Forecast Growth

RYAN has been the subject of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a report on Tuesday. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Friday, January 10th. Finally, The Goldman Sachs Group lifted their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $74.40.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Bar Harbor Wealth Management raised its position in shares of Ryan Specialty by 5.9% in the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after acquiring an additional 9,482 shares in the last quarter. Cooper Financial Group grew its stake in Ryan Specialty by 9.9% during the fourth quarter. Cooper Financial Group now owns 3,808 shares of the company’s stock worth $244,000 after purchasing an additional 342 shares during the period. GAMMA Investing LLC grew its stake in Ryan Specialty by 38.1% during the fourth quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock worth $111,000 after purchasing an additional 476 shares during the period. JPMorgan Chase & Co. increased its holdings in Ryan Specialty by 107.5% in the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after purchasing an additional 238,064 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock valued at $56,545,000 after buying an additional 509,548 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.